Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ZTS · against 1,372 other Healthcare companies
Ranked #1,243 of 1,373 · scores higher than 9% of peers · safety percentile 9
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)138 peers with a safety percentile of 0–9, including ZTS · Click a bar to see the companies
Mainly because of its debt / equity and beta, which are weaker than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ZTS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 1,280 reported | 2.94× | 0.24× | 4% | 33% | |
| BetaLower is better · 1,320 reported | 0.73 | 0.53 | 38% | 33% | |
| Current ratioHigher is better · 1,338 reported | 3.08× | 2.62× | 57% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 1,239 | 1.2B SGD (≈$945M) | 10 | 35 | |
| 1,240 | 320M USD | 10 | 44 | |
| 1,241 | 1.1B USD | 10 | 31 | |
| 1,242 | 12.7B AUD (≈$8.4B) | 10 | 38 | |
| 1,243 | 34.3B USD | 9 | 57 | |
| 1,244 | 2.2B USD | 9 | 32 | |
| 1,245 | 336M USD | 9 | 43 | |
| 1,246 | 3.0B USD | 9 | 35 | |
| 1,247 | 207.7B USD | 9 | 18 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score